AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
DEALING WITH DRUG-INDUCED THROMBOCYTOPENIA
Authors: KELTON JG CASSILETH PA
Citation: Jg. Kelton et Pa. Cassileth, DEALING WITH DRUG-INDUCED THROMBOCYTOPENIA, Hospital practice, 33(5), 1998, pp. 37
INTERLEUKIN-2 THERAPY FOR ADVANCED CHRONIC MYELOID-LEUKEMIA
Authors: GOODMAN M SPECTOR N RODRIGUES G CASSILETH PA
Citation: M. Goodman et al., INTERLEUKIN-2 THERAPY FOR ADVANCED CHRONIC MYELOID-LEUKEMIA, Leukemia, 12(11), 1998, pp. 1682-1684
METAANALYSIS OF CHEMOTHERAPY VERSUS COMBINED-MODALITY TREATMENT TRIALS IN HODGKINS-DISEASE
Authors: LOEFFLER M BROSTEANU O HASENCLEVER D SEXTRO M ASSOULINE D BARTOLUCCI AA CASSILETH PA CROWTHER D DIEHL V FISHER RI HOPPE RT JACOBS P PATER JL PAVLOVSKY S THOMPSON E WIERNIK P
Citation: M. Loeffler et al., METAANALYSIS OF CHEMOTHERAPY VERSUS COMBINED-MODALITY TREATMENT TRIALS IN HODGKINS-DISEASE, Journal of clinical oncology, 16(3), 1998, pp. 818-829
ANALYSIS OF THE VALUE OF EMPIRIC VANCOMYCIN ADMINISTRATION IN FEBRILENEUTROPENIA OCCURRING AFTER AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS
Authors: KOYA R ANDERSEN J FERNANDEZ H GOODMAN M SPECTOR N SMITH R HANLON J CASSILETH PA
Citation: R. Koya et al., ANALYSIS OF THE VALUE OF EMPIRIC VANCOMYCIN ADMINISTRATION IN FEBRILENEUTROPENIA OCCURRING AFTER AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS, Bone marrow transplantation, 21(9), 1998, pp. 923-926
A PHASE-II TRIAL OF NEOADJUVANT METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED BREAST-CARCINOMA
Authors: MORRELL LE LEE YJ HURLEY J ARIAS M MIES C RICHMAN SP FERNANDEZ H DONOFRIO KA RAUB WA CASSILETH PA
Citation: Le. Morrell et al., A PHASE-II TRIAL OF NEOADJUVANT METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED BREAST-CARCINOMA, Cancer, 82(3), 1998, pp. 503-511
ACUTE MYELOID-LEUKEMIA EXPRESSING THE LEUKOCYTE INTEGRIN CD11B - A NEW LEUKEMIC SYNDROME WITH POOR-PROGNOSIS - RESULT OF AN ECOG DATABASE ANALYSIS
Authors: PAIETTA E ANDERSEN J YUNIS J ROWE JM CASSILETH PA TALLMAN MS BENNETT JM WIERNIK PH
Citation: E. Paietta et al., ACUTE MYELOID-LEUKEMIA EXPRESSING THE LEUKOCYTE INTEGRIN CD11B - A NEW LEUKEMIC SYNDROME WITH POOR-PROGNOSIS - RESULT OF AN ECOG DATABASE ANALYSIS, British Journal of Haematology, 100(2), 1998, pp. 265-272
BOTH SIDES OF THE HYPERCOAGULABLE STATE
Authors: BENNETT JS CASSILETH PA
Citation: Js. Bennett et Pa. Cassileth, BOTH SIDES OF THE HYPERCOAGULABLE STATE, Hospital practice, 32(11), 1997, pp. 105
LONG-TERM SURVIVAL IN ACUTE MYELOID-LEUKEMIA - THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP EXPERIENCE
Authors: BENNETT JM YOUNG ML ANDERSEN JW CASSILETH PA TALLMAN MS PAIETTA E WIERNIK PH ROWE JM
Citation: Jm. Bennett et al., LONG-TERM SURVIVAL IN ACUTE MYELOID-LEUKEMIA - THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP EXPERIENCE, Cancer, 80(11), 1997, pp. 2205-2209
NOVEL DEFINITION OF UNDIFFERENTIATED (UNDIF) ACUTE MYELOID-LEUKEMIA (AML) BY LOW EXPRESSION OF THE CD65S CARBOHYDRATE MOLECULE - ANALYSIS OF 996 PATIENTS FROM THE ECOG DATABASE
Authors: PAIETTA E NEUBERG D BENNETT JM ROWE JM CASSILETH PA WIERNIK PH
Citation: E. Paietta et al., NOVEL DEFINITION OF UNDIFFERENTIATED (UNDIF) ACUTE MYELOID-LEUKEMIA (AML) BY LOW EXPRESSION OF THE CD65S CARBOHYDRATE MOLECULE - ANALYSIS OF 996 PATIENTS FROM THE ECOG DATABASE, Blood, 90(10), 1997, pp. 3723-3723
LONG-TERM RESULTS IN HAIRY-CELL LEUKEMIA (HCL) TREATED WITH PENTOSTATIN
Authors: FLINN IW KOPECKY KJ FOUCAR MK HEAD D BENNETT JM HUTCHISON RE CORBETT WEN CASSILETH PA HABERMANN T GOLOMB H RAI K EISENHAUER E APPELBAUM FR CHESON BD GREVER M
Citation: Iw. Flinn et al., LONG-TERM RESULTS IN HAIRY-CELL LEUKEMIA (HCL) TREATED WITH PENTOSTATIN, Blood, 90(10), 1997, pp. 2575-2575
TREATMENT OF ADULT PATIENTS WITH ACUTE LYMPHOCYTIC-LEUKEMIA IN RELAPSE
Authors: MAZZA JJ LEONG T ROWE JM WIERNIK PH CASSILETH PA
Citation: Jj. Mazza et al., TREATMENT OF ADULT PATIENTS WITH ACUTE LYMPHOCYTIC-LEUKEMIA IN RELAPSE, Leukemia & lymphoma, 20(3-4), 1996, pp. 317-319
MORPHOLOGIC CLASSIFICATION OF ACUTE MYELOID-LEUKEMIA - CONCORDANCE AMONG EASTERN-COOPERATIVE-ONCOLOGY-GROUP INVESTIGATORS - A COMMENT
Authors: BENNETT JM CASSILETH PA PAIETTA E ROWE JM WIERNIK PH
Citation: Jm. Bennett et al., MORPHOLOGIC CLASSIFICATION OF ACUTE MYELOID-LEUKEMIA - CONCORDANCE AMONG EASTERN-COOPERATIVE-ONCOLOGY-GROUP INVESTIGATORS - A COMMENT, Leukemia, 10(8), 1996, pp. 1365-1365
CENTRAL-NERVOUS-SYSTEM (CNS) PROPHYLAXIS IS UNNECESSARY IN OCULAR ADNEXAL LYMPHOMA (OAL)
Authors: RESTREPO A JOHNSON T BYRNE GE BENEDETTO P WHITCOMB CC TSE D VOIGT W CASSILETH PA
Citation: A. Restrepo et al., CENTRAL-NERVOUS-SYSTEM (CNS) PROPHYLAXIS IS UNNECESSARY IN OCULAR ADNEXAL LYMPHOMA (OAL), Blood, 88(10), 1996, pp. 897-897
12 WEEKS OF CHEMOTHERAPY (STANFORD V) AND INVOLVED FIELD RADIOTHERAPY(RT) ARE HIGHLY EFFECTIVE FOR BULKY AND ADVANCED-STAGE HODGKINS-DISEASE (HD) - A LIMITED INSTITUTION ECOG PILOT-STUDY
Authors: HORNING SJ BENNETT JM BARTLETT NL WILLIAMS J NEUBERG D CASSILETH PA
Citation: Sj. Horning et al., 12 WEEKS OF CHEMOTHERAPY (STANFORD V) AND INVOLVED FIELD RADIOTHERAPY(RT) ARE HIGHLY EFFECTIVE FOR BULKY AND ADVANCED-STAGE HODGKINS-DISEASE (HD) - A LIMITED INSTITUTION ECOG PILOT-STUDY, Blood, 88(10), 1996, pp. 2681-2681
PHASE-I STUDY OF TRANSFECTED CANCER-CELLS EXPRESSING THE INTERLEUKIN-2 GENE-PRODUCT IN LIMITED STAGE SMALL-CELL LUNG-CANCER
Authors: CASSILETH PA PODACK E SRIDHAR K SAVARAJ N HANLON J
Citation: Pa. Cassileth et al., PHASE-I STUDY OF TRANSFECTED CANCER-CELLS EXPRESSING THE INTERLEUKIN-2 GENE-PRODUCT IN LIMITED STAGE SMALL-CELL LUNG-CANCER, Human gene therapy, 6(3), 1995, pp. 369-383
RANDOMIZED COMPARISON OF PENTOSTATIN VERSUS INTERFERON ALFA-2A IN PREVIOUSLY UNTREATED PATIENTS WITH HAIRY-CELL LEUKEMIA - AN INTERGROUP STUDY
Authors: GREVER M KOPECKY K FOUCAR MK HEAD D BENNETT JM HUTCHISON RE CORBETT WEN CASSILETH PA HABERMANN T GOLOMB H RAI K EISENHAUER E APPELBAUM F CHESON BD
Citation: M. Grever et al., RANDOMIZED COMPARISON OF PENTOSTATIN VERSUS INTERFERON ALFA-2A IN PREVIOUSLY UNTREATED PATIENTS WITH HAIRY-CELL LEUKEMIA - AN INTERGROUP STUDY, Journal of clinical oncology, 13(4), 1995, pp. 974-982
THE TREATMENT OF OLDER ADULT PATIENTS WITH ACUTE MYELOID-LEUKEMIA BY TRIPLE INFUSION CHEMOTHERAPY
Authors: FRIEDENBERG WR MILLER HJ MARX JJ SCHLOESSER LL REDING DJ MAZZA JJ HOCKING WG MERCIER RJ RAICH PC CASSILETH PA
Citation: Wr. Friedenberg et al., THE TREATMENT OF OLDER ADULT PATIENTS WITH ACUTE MYELOID-LEUKEMIA BY TRIPLE INFUSION CHEMOTHERAPY, American journal of clinical oncology, 18(2), 1995, pp. 105-110
ADVANCED DIFFUSE NON-HODGKINS-LYMPHOMA - ANALYSIS OF PROGNOSTIC FACTORS BY THE INTERNATIONAL INDEX AND BY LACTIC-DEHYDROGENASE IN AN INTERGROUP STUDY
Authors: GORDON LI ANDERSEN J COLGAN J GLICK J RESNICK GD OCONNELL M CASSILETH PA
Citation: Li. Gordon et al., ADVANCED DIFFUSE NON-HODGKINS-LYMPHOMA - ANALYSIS OF PROGNOSTIC FACTORS BY THE INTERNATIONAL INDEX AND BY LACTIC-DEHYDROGENASE IN AN INTERGROUP STUDY, Cancer, 75(3), 1995, pp. 865-873
A RANDOMIZED PLACEBO-CONTROLLED PHASE-III STUDY OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN ADULT PATIENTS (GREATER-THAN-55 TO 70 YEARS OF AGE) WITH ACUTE MYELOGENOUS LEUKEMIA - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (E1490)
Authors: ROWE JM ANDERSEN JW MAZZA JJ BENNETT JM PAIETTA E HAYES FA OETTE D CASSILETH PA STADTMAUER EA WIERNIK PH
Citation: Jm. Rowe et al., A RANDOMIZED PLACEBO-CONTROLLED PHASE-III STUDY OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN ADULT PATIENTS (GREATER-THAN-55 TO 70 YEARS OF AGE) WITH ACUTE MYELOGENOUS LEUKEMIA - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (E1490), Blood, 86(2), 1995, pp. 457-462
USE OF G-CSF MOBILIZED ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) COLLECTED BY LARGE-VOLUME LEUKAPHERESIS (LVL)
Authors: FERNANDEZ HF SPECTOR N GOODMAN M NOTO TA REIK R CASSILETH PA
Citation: Hf. Fernandez et al., USE OF G-CSF MOBILIZED ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) COLLECTED BY LARGE-VOLUME LEUKAPHERESIS (LVL), Blood, 86(10), 1995, pp. 2312-2312
HIGH-DOSE CONTINUOUS-INFUSION VP-16, IFOSFAMIDE, SOLUMEDROL AND INTERLEUKIN-2 (VISIT) IN RELAPSED LYMPHOMA AND REFRACTORY HEMATOLOGIC MALIGNANCIES
Authors: GOODMAN M SPECTOR N FERNANDEZ HF CASSILETH PA HURLEY J
Citation: M. Goodman et al., HIGH-DOSE CONTINUOUS-INFUSION VP-16, IFOSFAMIDE, SOLUMEDROL AND INTERLEUKIN-2 (VISIT) IN RELAPSED LYMPHOMA AND REFRACTORY HEMATOLOGIC MALIGNANCIES, Blood, 86(10), 1995, pp. 3240-3240
EARLY ENGRAFTMENT OF MOBILIZED AUTOLOGOUS PERIPHERAL-BLOOD PROGENITORCELLS (PBPC) COLLECTED BY LARGE-VOLUME LEUKAPHERESIS (LVL)
Authors: FERNANDEZ HF NOTO TA MORRELL L SPECTOR N GOODMAN M SMITH RJ COLLIER T CASSILETH PA
Citation: Hf. Fernandez et al., EARLY ENGRAFTMENT OF MOBILIZED AUTOLOGOUS PERIPHERAL-BLOOD PROGENITORCELLS (PBPC) COLLECTED BY LARGE-VOLUME LEUKAPHERESIS (LVL), Blood, 84(10), 1994, pp. 10000094-10000094
TRAINING IN SUBSPECIALTY INTERNAL-MEDICINE - ON THE CHESSBOARD OF HEALTH-CARE REFORM
Authors: ADKINSON NF ALPERT JS LORIAUX DL LADENSON PW FRIEDMAN LS CASSILETH PA KAUFMAN RE BARTLETT JG KLEMPNER MS NEILSON EG GLICK JH MAYER RJ KOERNER SK CRANDALL ED AREND WP
Citation: Nf. Adkinson et al., TRAINING IN SUBSPECIALTY INTERNAL-MEDICINE - ON THE CHESSBOARD OF HEALTH-CARE REFORM, Annals of internal medicine, 121(10), 1994, pp. 810-813
MODIFIED VINCRISTINE, DOXORUBICIN, AND DEXAMETHASONE REGIMEN IN THE TREATMENT OF RESISTANT OR RELAPSED CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: FRIEDENBERG WR ANDERSON J WOLF BC CASSILETH PA OKEN MM
Citation: Wr. Friedenberg et al., MODIFIED VINCRISTINE, DOXORUBICIN, AND DEXAMETHASONE REGIMEN IN THE TREATMENT OF RESISTANT OR RELAPSED CHRONIC LYMPHOCYTIC-LEUKEMIA, Cancer, 71(10), 1993, pp. 2983-2989
CHEMOTHERAPY G-CSF PRIMED PERIPHERAL-BLOOD STEM-CELLS (PBSC) ALONE ARE SUFFICIENT FOR RAPID HEMATOPOIETIC RECONSTITUTION OF PLATELETS AND MYELOID CELLS AFTER MYELOABLATIVE CHEMOTHERAPY/
Authors: MAHARAJ D GUERRA M MORRELL L SMITH R HANLON J CASSILETH PA
Citation: D. Maharaj et al., CHEMOTHERAPY G-CSF PRIMED PERIPHERAL-BLOOD STEM-CELLS (PBSC) ALONE ARE SUFFICIENT FOR RAPID HEMATOPOIETIC RECONSTITUTION OF PLATELETS AND MYELOID CELLS AFTER MYELOABLATIVE CHEMOTHERAPY/, Blood, 82(10), 1993, pp. 10000083-10000083
Risultati: 1-25 | 26-29